ViroVet
La probabilité de faillite calculée de ViroVet sur 12 mois est de 0,3% (très faible). L'entreprise est active depuis 2015 et le Moniteur belge ne contient aucun signal d'insolvabilité ou d'avertissement. Aucun chiffre de comptes annuels traité n'est disponible ; cette conclusion repose uniquement sur les données du registre et du Moniteur belge.
| Active | 10 ans |
| Direction | 14 |
| Sites | 1 |
| Publications | 55 |
Estimation statistique fondée sur des sources publiques — pas un conseil de crédit ni une constatation. Comment calculons-nous cela ?
| Exercice | Type | Dépôt | Référence |
|---|---|---|---|
| 31-12-2024 | volledig | 01-07-2025 | 2025-00205904 |
| 31-12-2023 | volledig | 27-05-2024 | 2024-00096420 |
| 31-12-2022 | volledig | 24-05-2023 | 2023-00094930 |
| 31-12-2021 | volledig | 16-06-2022 | 2022-20066095 |
| 31-12-2020 | volledig | 07-06-2021 | 2021-17700020 |
| 31-12-2019 | volledig | 26-05-2020 | 2020-13000397 |
| 31-12-2018 | volledig | 28-05-2019 | 2019-14900173 |
| 31-12-2017 | volledig | 31-05-2018 | 2018-15300473 |
| 31-12-2016 | volledig | 22-05-2017 | 2017-12900294 |
-
VIVES PARTNERSPersonne moraleAdministrateur· repr. perm.: Yannick VancoppenolleActe Moniteur 24091814 (18-06-2024)Actif31-01-2024 → auj.
-
Esbee BVPersonne moraleAdministrateur délégué· repr. perm.: Erwin BlomsmaActe Moniteur 22067467 (07-06-2022)Actif07-06-2022 → auj.
-
Actif30-09-2021 → auj.
-
BIOTECH FONDS VLAANDERENPersonne moraleAdministrateur· repr. perm.: GOOSSENS FilipActe Moniteur 21074597 (23-06-2021)Actif09-02-2021 → auj.
-
SOPARTECPersonne moraleAdministrateur· repr. perm.: VANCOPPENOLLE YannickActe Moniteur 21074597 (23-06-2021)Actif10-07-2020 → auj.
-
Actif06-06-2020 → auj.
-
SEVENTURE PARTNERS SAPersonne moraleAdministrateur· repr. perm.: GERBE Laetitia AnnieActe Moniteur 20326282 (15-06-2020)Actif28-05-2020 → auj.
-
Biotech Fonds VlaanderenPersonne moraleAdministrateur· repr. perm.: WILS Kenneth Maria J.Acte Moniteur 20326282 (15-06-2020)Actif07-04-2020 → auj.
-
ESBEEPersonne moraleAdministrateur délégué· repr. perm.: Erwin BlomsmaActe Moniteur 17115990 (09-08-2017)Actif12-07-2017 → auj.
-
Actif28-12-2016 → auj.
-
Actif28-12-2016 → auj.
-
SOPARTECPersonne moraleAdministrateur· repr. perm.: Filip GoossensActe Moniteur 17016279 (30-01-2017)Actif28-12-2016 → auj.
-
Actif17-08-2015 → auj.
3 événements
- 30-01-2017 Nommé· Administrateur
- 17-08-2015 Nommé· Gérant
- 13-08-2015 Démission· Gérant
-
Esbee BVBAPersonne moraleGérant· repr. perm.: Erwin BlomsmaActe Moniteur 15125347 (02-09-2015)Actif13-08-2015 → auj.
Anciens dirigeants (4)
-
Ancien— → 30-09-2021
-
Ancien— → 06-06-2020
-
Ancien— → 30-01-2017
-
EsbeePersonne moraleAdministrateur· repr. perm.: Erwin BlomsmaActe Moniteur 17016279 (30-01-2017)Ancien— → 28-12-2016
| Commissaire / réviseur | Numéro IRE/IBR | Période |
|---|---|---|
| Baker Tilly Belgium bedrijfsrevisorenActif Réviseur d'entreprises · représenté par Peter Weyers |
— | 17-01-2017 → auj. |
| BV PwC BedrijfsrevisorenActif Commissaire · représenté par Griet Helsen |
— | 19-06-2020 → auj. |
| NACE primaire | 72101 |
| Forme juridique | SA(014) |
| Date de constitution | 06-08-2015 |
| Status | Actif |
| Code postal | 3001 |
Parcelles liées à cette entreprise via ses adresses BCE (siège, unités d'établissement, succursales), croisées avec le plan parcellaire cadastral. Ceci montre où l'entreprise est active — pas un registre de propriété.
| Parcelle (capakey) | Région | Superficie | Bâtiments | Hauteur / ét. |
|---|---|---|---|---|
| 24514C0015/00Z002 | Flandre | 2 862 m² | 1 · 838 m² | 8,7 m · 2 ét. |
Une seule chronologie de tout ce qui est arrivé à cette entreprise — publications, événements d'insolvabilité et de cycle de vie, changements administratifs et comptes annuels déposés.
23-03-2026 1 administrateur nommé, 1 démissionnaire
- Griet Helsen — Commissaris
- Kevin Veestraeten — Commissaris
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Griet Helsen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Kevin Veestraeten",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}23-03-2026 Griet Helsen reconduit comme commissaire
- Griet Helsen — Commissaris
Détails techniques
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Griet Helsen",
"address": null,
"birth_date": null,
"profession": "bedrijfsrevisor",
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": null,
"name": "Griet Helsen BV",
"address": null,
"country": null,
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": "2025-07-01",
"evidence_quote": "De algemene vergadering neemt akte van de wijziging van de vaste vertegenwoordiger van de vennootschap PwC Bedrijfsrevisoren BV, met zetel te 1831 Diegem, Culliganlaan 5, en met ondernemingsnummer 0429.501.944, die overeenkomstig artikel 3:60 WVV vanaf 1 juli 2025 zal vertegenwoordigd worden door Gr",
"decharge_status": null,
"mandate_duration": {
"kind": "until_date",
"value": "2025-07-01"
},
"rep_rotation_new_rep": "Griet Helsen",
"rep_rotation_old_rep": "Kevin Veestraeten",
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": null,
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Bijzondere volmacht wordt verleend aan Xerius Contact VZW, met zetel te Brouwersvliet 4, bus 1, 2000 Antwerpen en met ondernemingsnummer 0410.958.217, RPR Antwerpen, afdeling Antwerpen met inbegrip van elke bestuurder, vertegenwoordiger, werknemer, bediende of aangestelde van Xerius Contact VZW, spe",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "sole_shareholder_declaration",
"role": null,
"person": {
"rrn": null,
"name": "Viktorija Coric",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2026-03-23",
"filing_date": "2026-03-13",
"act_kind_objet": "Commissaris"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2025-12-04",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet",
"legal_form": "Naamloze vennootschap"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Viktorija Coric",
"org_rep_person_name": null,
"person_role_at_subject": "Lasthebber"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}24-01-2025 1 administrateur nommé, 1 démissionnaire
- Erwin Blomsma — Gedelegeerd bestuurder
- Seventure Partners SA — Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": null,
"reason": "de_plein_droit_dissolution",
"subkind": null,
"via_org": {
"kbo": "0661.711.333",
"name": "Seventure Partners SA",
"address": "Rue de Monttessuy 5-7, 75007 Parijs",
"country": "FR",
"legal_form": "SA"
},
"statutory": null,
"compensated": null,
"effective_date": "2024-10",
"evidence_quote": "De vergadering neemt kennis van en aanvaardt het ontslag van de volgende bestuurder, met ingang vanaf oktober 2024: - de vennootschap naar Frans recht \u0022Seventure Partners SA\u0022",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "rep_rotation",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "Kevin Veestraeten",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "renewal",
"via_org": {
"kbo": "0429.501.944",
"name": "PwC Bedrijfsrevisoren BV/ PwC Reviseurs d\u0027Entreprises SRL",
"address": "Culliganlaan 5, 1831 Diegem",
"country": "BE",
"legal_form": "BV"
},
"statutory": null,
"compensated": null,
"effective_date": "2024-07-15",
"evidence_quote": "PwC Bedrijfsrevisoren BV/ PwC Reviseurs d\u0027Entreprises SRL stelt in overeenstemming met artikel 3:60 van het Wetboek van Vennootschappen en Verenigingen, in haar hoedanigheid van Commissaris, Kevin Veestraeten BV aan als haar vaste vertegenwoordiger vanaf 15 juli 2024 ter vervanging van Griet Helsen ",
"decharge_status": null,
"mandate_duration": {
"kind": "until_date",
"value": "2024-07-15"
},
"rep_rotation_new_rep": "Kevin Veestraeten BV",
"rep_rotation_old_rep": "Griet Helsen BV",
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": null,
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "Gedelegeerd bestuurder",
"person": {
"rrn": null,
"name": "Erwin Blomsma",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "Esbee BV",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2025-01-24",
"filing_date": "2024-11-15",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2024-11-15",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet",
"legal_form": "Naamloze vennootschap"
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}24-01-2025 Changement au sein de l'organe d'administration
Détails techniques
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
}
}24-01-2025 1 administrateur nommé, 1 démissionnaire
- Kevin Veestraeten BV — Vaste vertegenwoordiger commissaris
- GERBE Laetitia — Vaste vertegenwoordiger commissaris
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "vaste vertegenwoordiger commissaris",
"person": {
"rrn": null,
"name": "GERBE Laetitia",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vaste vertegenwoordiger commissaris",
"person": {
"rrn": null,
"name": "Kevin Veestraeten BV",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}18-06-2024 1 administrateur nommé, 1 démissionnaire
- VIVES PARTNERS SRL — Bestuurder
- SOPARTEC SA — Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "VIVES PARTNERS SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "SOPARTEC SA",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}18-06-2024 1 administrateur nommé, 1 démissionnaire
- Yannick Vancoppenolle — Bestuurder
- SOPARTEC SA — Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "SOPARTEC SA",
"address": null,
"birth_date": null
},
"effective_date": "2024-01-31",
"evidence_quote": "\u0022SOPARTEC SA\u0022, met zetel te 1348 Louvain-la-Neuve, Place de l\u0027Universit\u00E9 16 / 27 en met ondernemingsnummer 0402.978,679 wordt vervangen door \u0022VIVES PARTNERS SRL\u0022, met zetel te 1300 Waver, Chemin du Stocquoy 1 en met ondernemingsnummer 1004.227.835, met als vaste vertegenwoordiger Yannick Vancoppenol"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Yannick Vancoppenolle",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "1004227835",
"name": "VIVES PARTNERS SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-01-31",
"evidence_quote": "\u0022SOPARTEC SA\u0022, met zetel te 1348 Louvain-la-Neuve, Place de l\u0027Universit\u00E9 16 / 27 en met ondernemingsnummer 0402.978,679 wordt vervangen door \u0022VIVES PARTNERS SRL\u0022, met zetel te 1300 Waver, Chemin du Stocquoy 1 en met ondernemingsnummer 1004.227.835, met als vaste vertegenwoordiger Yannick Vancoppenol"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
}
}09-02-2024 Changement au sein de l'organe d'administration
Détails techniques
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
}
}09-02-2024 1 administrateur nommé, 1 démissionnaire
- BEKE Thomas — Bestuurder
- GUNN George William — Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "GUNN George William",
"address": "Charibury Road 24, OX2 6UU Oxford, Verenigd Koninkrijk",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_dissolution",
"subkind": "regular",
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": "2023-10-06",
"evidence_quote": "De vergadering neemt kennis van en aanvaardt het ontslag van de volgende bestuurder, met ingang vanaf 6 oktober 2023:",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "rep_rotation",
"role": "vaste_vertegenwoordiger",
"person": {
"rrn": null,
"name": "GOOSSENS Filip",
"address": "Oude Graanmarkt 63, 1000 Brussel",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "successor_conditional",
"via_org": {
"kbo": "0454.215.168",
"name": "Biotech Fonds Vlaanderen",
"address": "Oude Graanmarkt 63, 1000 Brussel",
"country": "BE",
"legal_form": "NV"
},
"statutory": "coopted",
"compensated": null,
"effective_date": "2023-11-13",
"evidence_quote": "de naamloze vennootschap \u0022Biotech Fonds Vlaanderen\u0022, met zetel te 1000 Brussel, Oude Graanmarkt 63 en met ondernemingsnummer 0454.215.168 heeft beslist om de heer GOOSSENS Filip te vervangen door de heer BEKE Thomas, woonplaats kiezende te 1000 Brussel, Oude Graanmarkt 63, als vaste vertegenwoordige",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": "BEKE Thomas",
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "BEKE Thomas",
"address": "Oude Graanmarkt 63, 1000 Brussel",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "regular",
"via_org": {
"kbo": "0454.215.168",
"name": "Biotech Fonds Vlaanderen",
"address": "Oude Graanmarkt 63, 1000 Brussel",
"country": "BE",
"legal_form": "NV"
},
"statutory": null,
"compensated": null,
"effective_date": "2023-11-13",
"evidence_quote": "de naamloze vennootschap \u0022Biotech Fonds Vlaanderen\u0022, met zetel te 1000 Brussel, Oude Graanmarkt 63 en met ondernemingsnummer 0454.215.168 heeft beslist om de heer GOOSSENS Filip te vervangen door de heer BEKE Thomas, woonplaats kiezende te 1000 Brussel, Oude Graanmarkt 63, als vaste vertegenwoordige",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": "GOOSSENS Filip",
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Leuven",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-02-09",
"filing_date": "2024-02-01",
"act_kind_objet": "Onderwerp akte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2023-11-29",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet",
"legal_form": "NV",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "Esbee BV",
"person_name": null,
"org_rep_person_name": "Erwin Blomsma",
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}09-02-2024 1 administrateur nommé, 1 démissionnaire
- BEKE Thomas — Vaste vertegenwoordiger
- GUNN George William — Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "GUNN George William",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vaste vertegenwoordiger",
"person": {
"rrn": null,
"name": "BEKE Thomas",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}27-06-2023 1 administrateur nommé, 1 démissionnaire
- BV PwC Bedrijfsrevisoren — Commissaris
- BV PwC Bedrijfsrevisoren — Commissaris
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "BV PwC Bedrijfsrevisoren",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "BV PwC Bedrijfsrevisoren",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}27-06-2023 Griet Helsen reconduit comme commissaire
- Griet Helsen — Commissaris
Détails techniques
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Griet Helsen",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "BV PwC Bedrijfsrevisoren",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "De algemene vergadering benoemt de BV PwC Bedrijfsrevisoren, met maatschappelijke zetel te 1831 Diegem, Culliganlaan 5, als Commissaris voor een termijn van drie jaar."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
}
}20-04-2023 Augmentation de capital de 920.900,24 € à 5.431.311,67 €
- €4.510.411,43 → €5.431.311,67
- 3 kapitaalbewegingen in deze akte
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"amount": 920900.24,
"currency": "EUR",
"after_eur": 5431311.67,
"delta_eur": 920900.24,
"before_eur": 4510411.43,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-04-06",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 920.900,24 EUR, om het van 4.510.411,43 EUR te brengen op 5.431.311,67 EUR, door inbreng in geld",
"contribution_type": "cash"
},
{
"kind": "capital_increase",
"amount": 578526.31,
"currency": "EUR",
"after_eur": 6009837.98,
"delta_eur": 578526.31,
"before_eur": 5431311.67,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-04-06",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap een tweede maal te verhogen met 578.526,31 EUR, om het te brengen van 5.431.311,67 EUR op 6.009.837,98 EUR, door incorporatie van het volledige bedrag van de uitgiftepremie in het kapitaal",
"contribution_type": "in_kind"
},
{
"kind": "capital_increase",
"amount": 0.08,
"currency": "EUR",
"after_eur": 6009838.06,
"delta_eur": 0.08,
"before_eur": 6009837.98,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-04-06",
"evidence_quote": "Het kapitaal van de vennootschap bedraagt zes miljoen negenduizend achthonderdachtendertig euro zes cent (\u20AC 6.009.838,06)",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
}
}20-04-2023 Augmentation de capital de 1.499.426,55 € à 6.009.837,98 €
- €4.510.411,43 → €6.009.837,98
- Inbreng in geld · Apport en numéraire
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 6009837.98,
"delta_eur": 1499426.5500000007,
"before_eur": 4510411.43,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}20-04-2023 Augmentation de capital de 920.900,24 € à 5.431.311,67 €
- €4.510.411,43 → €5.431.311,67
- Inbreng in geld · Apport en numéraire
- 2 kapitaalbewegingen in deze akte
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 5431311.67,
"delta_eur": 920900.24,
"before_eur": 4510411.43,
"share_emission": {
"agio_eur": 578526.31,
"share_form": "no_nominal_value",
"share_class": "Bevoorrechte C",
"n_new_shares": 48932,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 30.65
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 920900.24,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 6009837.98,
"delta_eur": 578526.31,
"before_eur": 5431311.67,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "kapitalisering_reserves",
"paid_up_delta_eur": 578526.31,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_distributable"
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Yorik DESMYTTERE",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2023-04-20",
"filing_date": "2023-04-18",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-04-06",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"uitgifte van het proces-verbaal",
"acht volmachten",
"het verslag van het bestuursorgaan",
"het verslag van de commissaris opgesteld overeenkomstig artikel 7:155 WVV",
"het verslag van het bestuursorgaan en het verslag van de commissaris opgesteld overeenkomstig artikel 7:180 WVV",
"de geco\u00F6rdineerde tekst van statuten"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 26666,
"class_name": "Gewone Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 105458,
"class_name": "Bevoorrechte A Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 76980,
"class_name": "Bevoorrechte B Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 79513,
"class_name": "Bevoorrechte C Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}23-06-2022 Modification des statuts
Détails techniques
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2022-06-16",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
},
"signature_regime": "joint_two",
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}23-06-2022 Réduction de capital de 5.420.708,96 € à 2.010.411,43 €
- €7.431.120,39 → €2.010.411,43
- 3 kapitaalbewegingen in deze akte
Détails techniques
{
"events": [
{
"kind": "capital_decrease",
"amount": 5420708.96,
"currency": "EUR",
"after_eur": 2010411.43,
"delta_eur": -5420708.96,
"before_eur": 7431120.39,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-06-16",
"evidence_quote": "De vergadering beslist het kapitaal, ter aanzuivering van geleden verliezen, in toepassing van artikel 7:210 van het Wetboek van vennootschappen en verenigingen, te verminderen ten belope van 5.420.708,96 EUR, om het te brengen van 7.431.120,39 EUR op 2.010.411,43 EUR, zonder vernietiging van aandelen.",
"contribution_type": null
},
{
"kind": "capital_increase",
"amount": 293883.41,
"currency": "EUR",
"after_eur": 2304294.84,
"delta_eur": 293883.41,
"before_eur": 2010411.43,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-06-16",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap te verhogen ten belope van 293.883,41 EUR, om het van 2.010.411,43 EUR te brengen op 2.304.294,84 EUR, door inbreng in geld en met de uitgifte van 30.581 nieuwe Bevoorrechte C Aandelen",
"contribution_type": "cash"
},
{
"kind": "capital_increase",
"amount": 2206116.59,
"currency": "EUR",
"after_eur": 4510411.43,
"delta_eur": 2206116.59,
"before_eur": 2304294.84,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-06-16",
"evidence_quote": "De vergadering beslist het kapitaal van de Vennootschap een tweede maal te verhogen met 2.206.116,59 EUR, om het te brengen van 2.304.294,84 EUR op 4.510.411,43 EUR, door incorporatie van het volledige bedrag van de uitgiftepremie in het kapitaal en zonder uitgifte van nieuwe aandelen.",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
}
}23-06-2022 Réduction de capital de 5.420.708,96 € à 2.010.411,43 €
- €7.431.120,39 → €2.010.411,43
- 5 kapitaalbewegingen in deze akte
Détails techniques
{
"events": [
{
"kind": "capital_decrease",
"after_eur": 2010411.43,
"delta_eur": -5420708.96,
"before_eur": 7431120.39,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": "loss_absorption",
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 2304294.84,
"delta_eur": 293883.41,
"before_eur": 2010411.43,
"share_emission": {
"agio_eur": 2206116.59,
"share_form": "no_nominal_value",
"share_class": "Bevoorrechte C",
"n_new_shares": 30581,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 81.74
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 293883.41,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": 30581,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 4510411.43,
"delta_eur": 2206116.59,
"before_eur": 2304294.84,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "kapitalisering_reserves",
"paid_up_delta_eur": 2206116.59,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_distributable"
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Tim CARNEWAL",
"firm_city": null,
"firm_name": "BERQUIN NOTARISSEN",
"office_city": "Brussel",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2022-06-23",
"filing_date": "2022-06-21",
"act_kind_objet": "Onderwerp akte:"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2022-06-16",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet",
"legal_form": "Naamloze vennootschap",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"plan financier",
"bankattest",
"verslag bedrijfsrevisor"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 26666,
"class_name": "Gewone Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 105458,
"class_name": "Bevoorrechte A Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 76980,
"class_name": "Bevoorrechte B Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 30581,
"class_name": "Bevoorrechte C Aandelen",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}23-06-2022 Modification des statuts
Détails techniques
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}23-06-2022 Augmentation de capital de 2.500.000 € à 4.510.411,43 €
- €2.010.411,43 → €4.510.411,43
- Inbreng in geld · Apport en numéraire
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 4510411.43,
"delta_eur": 2500000.0,
"before_eur": 2010411.43,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}07-06-2022 2 administrateurs nommés, 1 démissionnaire
- HAESEN Patrik — Bestuurder
- Erwin Blomsma — Gedelegeerd bestuurder
- Luc Basstanie — Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "HAESEN Patrik",
"address": null,
"birth_date": null
},
"effective_date": "2021-09-30",
"evidence_quote": "De vergadering erkent en bekrachtigt overeenkomstig artikel 7:88 van het Belgisch Wetboek van Vennootschappen en Verenigingen de benoeming van de volgende bestuurder: - geco\u00F6pteerd op voordracht van Agri Investment Fund CVBA bij besluit van de Raad van Bestuur de dato 5 oktober 2021: HAESEN Patrik, "
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Luc Basstanie",
"address": null,
"birth_date": null
},
"effective_date": "2021-09-30",
"evidence_quote": "De vergadering erkent en bekrachtigt overeenkomstig artikel 7:88 van het Belgisch Wetboek van Vennootschappen en Verenigingen de benoeming van de volgende bestuurder: - geco\u00F6pteerd op voordracht van Agri Investment Fund CVBA bij besluit van de Raad van Bestuur de dato 5 oktober 2021: HAESEN Patrik, "
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Erwin Blomsma",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Esbee BV",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Esbee BV, vertegenwoordigd door Erwin Blomsma Gedelegeerd bestuurder"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
}
}07-06-2022 HAESEN Patrik nommé administrateur
- HAESEN Patrik — Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "HAESEN Patrik",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}23-06-2021 3 administrateurs nommés, 1 démissionnaire
- SIENAERT Ilse — Bestuurder
- VANCOPPENOLLE Yannick — Bestuurder
- GOOSSENS Filip — Bestuurder
- Pierre Naassens — Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "SIENAERT Ilse",
"address": null,
"birth_date": null
},
"effective_date": "2020-06-06",
"evidence_quote": "De vergadering erkent en bekrachtigt overeenkomstig artikel 7:88 van het Belgisch Wetboek van Vennootschappen en Verenigingen de benoeming van de volgende bestuurder: - geco\u00F6pteerd op voordracht van Gemma Frisius Fonds K.U. Leuven NV bij besluit van de Raad van Bestuur de dato 15 juli 2020: SIENAERT"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Pierre Naassens",
"address": null,
"birth_date": null
},
"effective_date": "2020-06-06",
"evidence_quote": "De vergadering erkent en bekrachtigt overeenkomstig artikel 7:88 van het Belgisch Wetboek van Vennootschappen en Verenigingen de benoeming van de volgende bestuurder: - geco\u00F6pteerd op voordracht van Gemma Frisius Fonds K.U. Leuven NV bij besluit van de Raad van Bestuur de dato 15 juli 2020: SIENAERT"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "VANCOPPENOLLE Yannick",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0402978679",
"name": "Sopartec",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2020-07-10",
"evidence_quote": "de naamloze vennootschap \u0022Sopartec\u0022, met zetel te 1348 Louvain-la-Neuve, Chemin du Cyclotron 6 en met ondernemingsnummer 0402.978.679 heeft beslist om de heer GOOSSENS Filip als vaste vertegenwoordiger te vervangen door de heer VANCOPPENOLLE Yannick, wonende te 5080 Warisoulx, Rue de Namur 28 met in"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "GOOSSENS Filip",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0454215168",
"name": "Biotech Fonds Vlaanderen",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2021-02-09",
"evidence_quote": "de naamloze vennootschap \u0022Biotech Fonds Vlaanderen\u0022, met zetel te 1000 Brussel, Oude Graanmarkt 63 en met ondernemingsnummer 0454.215.168 heeft beslist om de heer WILS Kenneth te vervangen door de heer GOOSSENS Filip, wonende te 1910 Kampenhout, Van Bellinghenlaan 3 als vaste vertegenwoordiger met i"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
}
}23-06-2021 3 administrateurs nommés, 3 démissionnaires
- SIENAERT Ilse — Bestuurder
- VANCOPPENOLLE Yannick — Vaste vertegenwoordiger
- GOOSSENS Filip — Vaste vertegenwoordiger
- Pierre Naassens — Bestuurder
- GOOSSENS Filip — Vaste vertegenwoordiger
- WILS Kenneth — Vaste vertegenwoordiger
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "SIENAERT Ilse",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Pierre Naassens",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "vaste vertegenwoordiger",
"person": {
"rrn": null,
"name": "GOOSSENS Filip",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vaste vertegenwoordiger",
"person": {
"rrn": null,
"name": "VANCOPPENOLLE Yannick",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "vaste vertegenwoordiger",
"person": {
"rrn": null,
"name": "WILS Kenneth",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "vaste vertegenwoordiger",
"person": {
"rrn": null,
"name": "GOOSSENS Filip",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}19-06-2020 Griet Helsen reconduit comme commissaire
- Griet Helsen — Commissaris
Détails techniques
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Griet Helsen",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "BV PwC Bedrijfsrevisoren",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "De algemene vergadering benoemt de BV PwC Bedrijfsrevisoren, met zetel te 1932 Sint-Stevens-Woluwe Woluwedal 18, als Commissaris voor een termijn van drie jaar."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
}
}19-06-2020 1 administrateur nommé, 1 démissionnaire
- BV PwC Bedrijfsrevisoren — Commissaris
- Griet Helsen — Commissaris
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Griet Helsen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "BV PwC Bedrijfsrevisoren",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}15-06-2020 Augmentation de capital de 6.092.931,52 € à 11.544.734,35 €
- €5.451.802,83 → €11.544.734,35
- Inbreng in geld · Apport en numéraire
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 11544734.35,
"delta_eur": 6092931.52,
"before_eur": 5451802.83,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}15-06-2020 Modification des statuts
Détails techniques
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
},
"legal_form_change": {
"new": "Naamloze vennootschap",
"old": "Naamloze vennootschap",
"changed": false
}
}15-06-2020 9 administrateurs nommés, 1 démissionnaire
- Biotech Fonds Vlaanderen — Bestuurder
- Seventure Partners SA — Bestuurder
- Biotech Fonds Vlaanderen — Bestuurder
- Luc Jozef Maria Basstanie — Bestuurder
- George William Gunn — Bestuurder
- Pierre Eugène Naassen — Bestuurder
- SOPARTEC — Bestuurder
- Capricorn Partners — Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "David Jacques Martine Devigne",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Biotech Fonds Vlaanderen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Seventure Partners SA",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Biotech Fonds Vlaanderen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Luc Jozef Maria Basstanie",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "George William Gunn",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Pierre Eug\u00E8ne Naassen",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "SOPARTEC",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Capricorn Partners",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "ESBEE",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "ViroVet"
}
}15-06-2020 2 administrateurs nommés
- WILS Kenneth Maria J. — Bestuurder
- GERBE Laetitia Annie — Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "WILS Kenneth Maria J.",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Biotech Fonds Vlaanderen",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2020-04-07",
"evidence_quote": "I. De vergadering erkent en bekrachtigt de benoeming van de volgende bestuurder, geco\u00F6pteerd bij besluit van de Raad van Bestuur de dato 7 april 2020: de naamloze vennootschap \u0022Biotech Fonds Vlaanderen\u0022, met zetel te 1000 Brussel, Oude Graanmarkt 63, vast vertegenwoordigd door de heer WILS Kenneth M"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "GERBE Laetitia Annie",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Seventure Partners SA",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2020-05-28",
"evidence_quote": "De vergadering beslist op op voorstel van \u0022AVF FPCI\u0022, te benoemen als bestuurder, vanaf achtentwintig mei tweeduizend twintig en voor een duur die de zes jaar niet te boven gaat: de vennootschap naar Frans recht \u0022Seventure Partners SA\u0022, met zetel te 5-7 Rue de Monttessuy, 75007 Parijs, Frankrijk, va"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0634.891.328",
"name_full": "VIROVET",
"legal_form": "NV"
}
}Générez une note structurée et factuelle à partir de tous les signaux de ce dossier : risque, santé financière, structure de propriété, mandats et comparaison sectorielle.
| Dénomination légaleNL | ViroVet |